(Q44662454)

5 December 2017

title

Acute liver enzyme elevations in HIV-1-infected patients (English)

1 reference

5 December 2017

Catherine Quantin

8

0 references

author name string

Claire Livry

1

1 reference

5 December 2017

Christine Binquet

2

1 reference

5 December 2017

Catherine Sgro

3

1 reference

5 December 2017

Marie Froidure

4

1 reference

5 December 2017

Michel Duong

5

1 reference

5 December 2017

Marielle Buisson

6

1 reference

5 December 2017

Michèle Grappin

7

1 reference

5 December 2017

Henri Portier

9

1 reference

5 December 2017

Pascal Chavanet

10

1 reference

5 December 2017

Lionel Piroth

11

1 reference

5 December 2017

publication date

1 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

4

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

400-410

1 reference

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Severe hepatic failure related to nevirapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Analysis of multiple failure time data from an AIDS clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

Cox's Regression Model for Counting Processes: A Large Sample Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F2L6M-EE7G-5PGN-FJYP

10.1310/2L6M-EE7G-5PGN-FJYP

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference